|Age:||18 years or older|
|Keywords:||acute myeloid leukemia, AML, leukemia, Metastatic Castrate-Resistant Prostate Cancer, prostate cancer|
|Type:||Drug study, Phase 1|
The study team will make sure you qualify to take part in the study. Qualified participants will receive detailed information about the study. This may include a list of study-related tests and procedures.